Relaxin-2 for heart failure with preserved ejection fraction (HFpEF): Rationale for future clinical trials
Dschietzig, Thomas BerndLanguage:
english
Journal:
Molecular and Cellular Endocrinology
DOI:
10.1016/j.mce.2019.01.013
Date:
January, 2019
File:
PDF, 584 KB
english, 2019